Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...

Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen.

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

indicating that the autocrine loop of action of this hormone may be a new therapeutic target Dopamine agonists, the classical drugs used to decrease prolactin production and release from the ...

People will have their drug of choice, whether it’s shopping ... but there is clearly a signal that the GLP-1 agonists can help with alcohol addiction. We have patients in our clinic who have ...

The MHRA emphasised that patients should be asked whether they are taking GLP-1 or dual GIP/GLP-1 receptor agonists and that those who may have bought these drugs for “aesthetic weight loss” may not ...

Bright Minds Biosciences Inc. (NASDAQ:DRUG) has been able to initiate its phase 2 BREAKTHROUGH study using its 5-HT2C agonist BMB-101 for the treatment of adult patients with classic Absence ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality. By Alexandra Stevenson and Zixu Wang Reporting from Hong Kong A rare ...